Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Michael, Schlag"'
Autor:
Michael Schlag
Publikováno v:
Lärmbekämpfung. 17:104-107
Die vom Landesamt für Umwelt Bayern herausgegebene Parkplatzlärmstudie zeigt Prognoseansätze für die Spitzenpegel beim Schließen von Pkw-Türen und Kofferraumklappen auf. Die Prognoseansätze wurden aus Emissionsmessungen aus dem Jahr 1999 entwi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::702c9fc01f72076ef9b8d63139a76188
https://doi.org/10.37544/1863-4672-2022-04-14
https://doi.org/10.37544/1863-4672-2022-04-14
Autor:
Manisha Juneja, Dennis Kobelt, Wolfgang Walther, Cynthia Voss, Janice Smith, Edgar Specker, Martin Neuenschwander, Björn-Oliver Gohlke, Mathias Dahlmann, Silke Radetzki, Robert Preissner, Jens Peter von Kries, Peter Michael Schlag, Ulrike Stein
Publikováno v:
PLoS Biology, Vol 15, Iss 6, p e2000784 (2017)
MACC1 (Metastasis Associated in Colon Cancer 1) is a key driver and prognostic biomarker for cancer progression and metastasis in a large variety of solid tumor types, particularly colorectal cancer (CRC). However, no MACC1 inhibitors have been ident
Externí odkaz:
https://doaj.org/article/2c75230d61f7421f96fd23d8f6a02fd0
Autor:
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R Foster, Antonio Craxí, Peter Buggisch, Faisal Sanai, Ceyhun Bicer, Oliver Lenz, Gino Van Dooren, Catherine Nalpas, Isabelle Lonjon-Domanec, Michael Schlag, Maria Buti
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0168713 (2017)
BACKGROUND:HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. Primary study objectives were as
Externí odkaz:
https://doaj.org/article/4d509d8259cb43579a812ae4d13e2049
Autor:
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R Foster, Antonio Craxí, Peter Buggisch, Robert Ryan, Oliver Lenz, Jane Scott, Gino Van Dooren, Isabelle Lonjon-Domanec, Michael Schlag, Maria Buti
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0158526 (2016)
Shortening duration of peginterferon-based HCV treatment reduces associated burden for patients. Primary objectives of this study were to assess the efficacy against the minimally acceptable response rate 12 weeks post-treatment (SVR12) and safety of
Externí odkaz:
https://doaj.org/article/54261c713d544f2eb753bf8ae269e99f
Autor:
Thomas Knösel, Valeska Emde, Karsten Schlüns, Peter Michael Schlag, Manfred Dietel, Iver Petersen
Publikováno v:
Cellular Oncology, Vol 28, Iss 4, Pp 167-175 (2006)
Background and aims: Recent cDNA expression profiling analyses indicate that within specific organ cancers Cytokeratins (CKs) dysregulation may identify subgroups with distinct biological phenotypes. Our objectives in this study were (1) to test whet
Externí odkaz:
https://doaj.org/article/5bcb92837cf4415780c11e532f94fae6
Autor:
Thomas Knösel, Karsten Schlüns, Ulrike Stein, Holger Schwabe, Peter Michael Schlag, Manfred Dietel, Iver Petersen
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 1, Pp 23-28 (2004)
Comparative genomic hybridization (CGH) was used to screen colorectal carcinomas for chromosomal aberrations that are associated with metastatic phenotype. In total, 63 tumor specimens from 40 patients were investigated, comprising 30 primary tumors,
Externí odkaz:
https://doaj.org/article/ed79af34b7a74cb18a3bca947f6b1c09
Autor:
Ceyhun Bicer Ceyhun, John F. Dillon John, Maria Beumont Maria, Isabelle Lonjon-Domanec Isabelle, Michael Schlag Michael, Catherine Nalpas Catherine, Stefan Mauss Stefan, Ronald Kalmeijer Ronald, Wolfgang Jessner Wolfgang
Publikováno v:
Pharmateca. :32-40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eed22636988d2daf4a977571440d429
https://doi.org/10.18565/pharmateca.2018.9.32-40
https://doi.org/10.18565/pharmateca.2018.9.32-40
Autor:
Fiona, Marra, Christoph, Höner Zu Siederdissen, Saye, Khoo, David, Back, Michael, Schlag, Sivi, Ouwerkerk-Mahadevan, Ceyhun, Bicer, Isabelle, Lonjon-Domanec, Wolfgang, Jessner, Maria, Beumont-Mauviel, Ronald, Kalmeijer, Markus, Cornberg
Publikováno v:
British Journal of Clinical Pharmacology
Aims Direct‐acting antiviral agents (DAAs) for the treatment of hepatitis C (HCV) can be associated with drug–drug interactions (DDIs) with concomitant medications. The practical clinical implications of such DDIs are poorly understood. We assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f071be30270da6029024a2b808acccb
https://pubmed.ncbi.nlm.nih.gov/29345798
https://pubmed.ncbi.nlm.nih.gov/29345798
Autor:
Gianpiero, D'Offizi, Calogero, Cammà, Chiara, Taibi, Michael, Schlag, Karin, Weber, Maria, Palma, Ralph, DeMasi, Katrien, Janssen, James, Witek, Raffaella, Lionetti
Publikováno v:
The new microbiologica. 40(1)
Simeprevir plus peg-interferon/ribavirin (PR) is approved to treat chronic hepatitis C (HCV) genotype 1 (GT1) and GT4 infection. This study aimed to assess baseline and on-treatment the factors predictive of sustained virologic response 12-weeks post
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9c357d31a3f11b200dde15d6862f5f7
https://pubmed.ncbi.nlm.nih.gov/28072888
https://pubmed.ncbi.nlm.nih.gov/28072888
Autor:
Dirk Grosenick, Felix Diekmann, Axel Hagen, Alexander Poellinger, Rainer Macdonald, Peter-Michael Schlag, F. Engelken, Susen Burock, Herbert Rinneberg, Lutz Lüdemann
Publikováno v:
Radiology. 258:409-416
To assess early- and late-fluorescence near-infrared imaging, corresponding to the vascular (early-fluorescence) and extravascular (late-fluorescence) phases of indocyanine green (ICG) enhancement, for breast cancer detection and benign versus malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df34b96ee059f05656cb7b2315035cbe
https://doi.org/10.1148/radiol.10100258
https://doi.org/10.1148/radiol.10100258